Therapeutic strategies for pigmented purpuric dermatoses: a systematic literature review

References

• Kazandjieva J, Antonov D, Kamarashev J, et al. Acrally distributed dermatoses: vascular dermatoses (Purpura and Vasculitis). Clin Dermatol. 2017;35:68–80.
   PubMed Web of Science ®Google Scholar
• Kim DH, Seo SH, Ahn HH, et al. Characteristics and clinical manifestations of pigmented purpuric dermatosis. Ann Dermatol. 2015;27:404–410.
   PubMed Web of Science ®Google Scholar
• Sharma L, Gupta S. Clinicoepidemiological study of pigmented purpuric dermatoses. Indian Dermatol Online J. 2012;3:17–20.
   PubMedGoogle Scholar
• Huang YK, Lin CK, Wu YH. The pathological spectrum and clinical correlation of pigmented purpuric dermatosis-A retrospective review of 107 cases. J Cutan Pathol. 2018;45:325–332.
   PubMed Web of Science ®Google Scholar
• García-Rodiño S, Rodríguez-Granados MT, Seoane-Pose MJ, et al. Granulomatous variant of pigmented purpuric dermatosis: report of two cases and review of the literature. J Dtsch Dermatol Ge. 2017;15:565–569.
   Web of Science ®Google Scholar
• Ma HJ, Zhao G, Liu W, et al. Unilateral linear capillaritis: two unusual Chinese cases. Eur J Dermatol. 2007;17:160–163.
   PubMed Web of Science ®Google Scholar
• Smoller BR, Kamel OW. Pigmented purpuric eruptions: immunopathologic studies. Supportive of a common immunophenotype. J Cutan Pathol. 1991;18:423–427.
   PubMed Web of Science ®Google Scholar
• Unal E, Ergül G. Pigmented purpuric dermatosis after taking a dietary supplement. Cutan Ocul Toxicol. 2016;35:260–262.
   PubMed Web of Science ®Google Scholar
• Taketuchi Y, Chinen T, Ichikawa Y, et al. Two cases of unilateral pigmented purpuric dermatosis. J Dermatol. 2001;28:493–498.
   PubMed Web of Science ®Google Scholar
• Cavalcante MLLL, Masuda PY, Brito FF, et al. Schamberg's disease: case report with therapeutic success by using colchicine. An Bras Dermatol. 2017;92:246–248.
   PubMed Web of Science ®Google Scholar
• Coulombe J, Jean SE, Hatami A, et al. Pigmented purpuric dermatosis: clinicopathologic characterization in a pediatric series. Pediatr Dermatol. 2015;32:358–362.
   PubMed Web of Science ®Google Scholar
• Sardana K, Sarkar R, Sehgal VN. Pigmented purpuric dermatoses: an overview. Int J Dermatol. 2004;43:482–488.
   PubMed Web of Science ®Google Scholar
• Kaplan J, Burgin S, Sepehr A. Granulomatous pigmented purpura: report of a case and review of the literature. J Cutan Pathol. 2011;38:984–989.
   PubMed Web of Science ®Google Scholar
• Murota H, Katayama I. Lichen aureus responding to topical tacrolimus treatment. J Dermatol. 2011;38:823–825.
   PubMed Web of Science ®Google Scholar
• Moche J, Glassman S, Modi D, et al. Segmental lichen aureus: a report of two cases treated with methylprednisolone aceponate. Australas J Dermatol. 2011;52:e15–e18.
   PubMed Web of Science ®Google Scholar
• Battle LR, Shalin SC, Gao L. Granulomatous pigmented purpuric dermatosis. Clin Exp Dermatol. 2015;40:387–390.
   PubMed Web of Science ®Google Scholar
• Kerns MJ, Mallatt BD, Shamma HN. Granulomatous pigmented purpura: an unusual histological variant. Am J Dermatopathol. 2009;31:77–80.
   PubMed Web of Science ®Google Scholar
• Allan A, Altman DA, Su W. Granulomatous pigmented purpuric dermatosis. Cutis. 2017;100:256–258.
   PubMed Web of Science ®Google Scholar
• Bohm M, Bonsmann G, Luger TA. Resolution of lichen aureus in a 10-year-old child after topical pimecrolimus. Br J Dermatol. 2004;151:519–520.
   PubMed Web of Science ®Google Scholar
• Schober SM, Peitsch WK, Bonsmann G, et al. Early treatment with rutoside and ascorbic acid is highly effective for progressive pigmented purpuric dermatosis. J Dtsch Dermatol Ges. 2014;12:1112–1119.
   PubMed Web of Science ®Google Scholar
• Laufer F. The treatment of progressive pigmented purpura with ascorbic acid and a bioflavonoid rutoside. J Drugs Dermatol. 2006;5:290–293.
   PubMedGoogle Scholar
• Reinhold U, Seiter S, Ugurel S, et al. Treatment of progressive pigmented purpura with oral bioflavonoids and ascorbic acid: an open pilot study in 3 patients. J Am Acad Dermatol. 1999;41:207–208.
   PubMed Web of Science ®Google Scholar
• Utoguchi N, Ikeda K, Saeki K, et al. Ascorbic acid stimulates barrier function of cultured endothelial cell monolayer. J Cell Physiol. 1995;163:393–399.
   PubMed Web of Science ®Google Scholar
• Peterkofsky B. Ascorbate requirement for hydroxylation and secretion of procollagen: relationship to inhibition of collagen synthesis in scurvy. Am J Clin Nutr. 1991;54:1135–1140.
   PubMed Web of Science ®Google Scholar
• Wiejak J, Dunlop J, Mackay SP, et al. Flavanoids induce expression of the suppressor of cytokine signalling 3 (SOCS3) gene and suppress IL-6-activated signal transducer and activator of transcription 3 (STAT3) activation in vascular endothelial cells. Biochem J. 2013;454:283–293.
   PubMed Web of Science ®Google Scholar
• Geller M. Benefit of colchicine in the treatment of Schamberg's disease. Ann Allergy Asthma Immunol. 2000;85:246.
   PubMed Web of Science ®Google Scholar
• Kano T, Hirayama K, Orihara M, et al. Successful treatment of Schamberg's disease with pentoxifylline. J Am Acad Dermatol. 1997;36:827–830.
   PubMed Web of Science ®Google Scholar
• Wahba-Yahav AV. Schamberg’s purpura: association with persistent hepatitis B surface antigenemia and treatment with pentoxifylline. Cutis. 1994;54:205–206.
   PubMed Web of Science ®Google Scholar
• Mun JH, Jwa SW, Song M, et al. Extensive pigmented purpuric dermatosis successfully treated with pentoxifylline. Ann Dermatol. 2012;24:363–365.
   PubMed Web of Science ®Google Scholar
• Lee HW, Lee DK, Chang SE, et al. Segmental lichen aureus: combination therapy with pentoxifylline and prostacyclin. J Eur Acad Dermatol Venerol. 2006;20:1378–1380.
   PubMed Web of Science ®Google Scholar
• Park JH, Kang HY. Generalized Schamberg disease in a child. Ann Dermatol. 2013;25:524–525.
   PubMed Web of Science ®Google Scholar
• Basak PY, Ergin S. Should pentoxifylline be regarded as an effective treatment for Schamberg’s disease? J Am Acad Dermatol. 2001;44:548–549.
   PubMed Web of Science ®Google Scholar
• Kumrah L, George R, George S. An open trial of pentoxifylline in schamberg’s disease. Indian J Dermatol Venereol Leprol. 2000;66:73–75.
   PubMedGoogle Scholar
• Tamaki K, Yasaka N, Osada A, et al. Successful treatment of pigmented purpuric dermatosis with griseofulvin. Br J Dermatol. 1995;132:159–160.
   PubMed Web of Science ®Google Scholar
• Okada K, Ishikawa O, Miyachi Y. Purpura pigmentosa chronica successfully treated with oral cyclosporin A. Br J Dermatol. 1996;134:180–181.
   PubMed Web of Science ®Google Scholar
• Hoesly FJ, Huerter CJ, Shehan JM. Purpura annularis telangiectodes of Majocchi: case report and review of the literature. Int J Dermatol. 2009;48:1129–1133.
   PubMed Web of Science ®Google Scholar
• Morrissey K, Rosenbach M, DeHoratius D, et al. Granulomatous changes associated with pigmented purpuric dermatosis. Cutis. 2014;94:197–202.
   PubMed Web of Science ®Google Scholar
• Wong WK, Ratnam KV. A report of two cases of pigmented purpuric dermatoses treated with PUVA therapy. Acta Derm Venereol. 1991;71:68–70.
   PubMed Web of Science ®Google Scholar
• Krizsa J, Hunyadi J, Dobozy A. PUVA treatment of pigmented purpuric lichenoid dermatitis (Gougerot-Blum). J Am Acad Dermatol. 1992;27:778–780.
   PubMed Web of Science ®Google Scholar
• Seckin D, Yazici Z, Senol A, et al. A case of Schamberg’s disease responding dramatically to PUVA treatment. Photodermatol Photoimmunol Photomed. 2008;24:95–96.
   PubMed Web of Science ®Google Scholar
• Lotti T, Ghersetich I, Panconesi E. Why should we use PUVA treatment in pigmented purpuric lichenoid dermatitis? J Am Acad Dermatol. 1994;30:145.
   PubMed Web of Science ®Google Scholar
• Ling TC, Goulden V, Goodfield MJ. PUVA therapy in lichen aureus. J Am Acad Dermatol. 2001;45:145–146.
   PubMed Web of Science ®Google Scholar
• Milea M, Dimov H-A, Cribier B. Generalized Schamberg’s disease treated with PUVA in a child. Ann Dermatol Venereol. 2007;134:378–380.
   PubMed Web of Science ®Google Scholar
• Gudi VS, White MI. Progressive pigmented purpura (Schamberg’s disease) responding to TL01 ultraviolet B therapy. Clin Exp Dermatol. 2004;29:683–684.
   PubMed Web of Science ®Google Scholar
• Fathy H, Abdelgaber S. Treatment of pigmented purpuric dermatoses with narrow-band UVB: a report of six cases. J Eur Acad Dermatol Venereol. 2011;25:603–606.
   PubMed Web of Science ®Google Scholar
• Kocaturk E, Kavala M, Zindanci I, et al. Narrowband UVB treatment of pigmented purpuric lichenoid dermatitis (Gougerot-Blum). Photodermatol Photoimmunol Photomed. 2009;25:55–56.
   PubMed Web of Science ®Google Scholar
• Lasocki AL, Kelly RI. Narrowband UVB therapy as an effective treatment for Schamberg’s disease. Australas J Dermatol. 2008;49:16–18.
   PubMed Web of Science ®Google Scholar
• Can B, Turkoglu Z, Kavala M, et al. Successful treatment of generalized childhood Schamberg's disease with narrowband ultravioletB therapy. Photodermatol Photoimmunol Photomed. 2011;27:216–218.
   PubMed Web of Science ®Google Scholar
• Karadag AS, Bilgili SG, Onder S, et al. Two cases of eczematid-like purpura of Doucas and Kapetanakis responsive to narrow band ultraviolet B treatment. Photodermatol Photoimmunol Photomed. 2013;29:97–99.
   PubMed Web of Science ®Google Scholar
• Ciudad C, Cano N, Suárez R. Satisfactory response to phototherapy in pigmented purpuric dermatosis. Actas Dermosifiliogr. 2013;104:439–440.
   PubMedGoogle Scholar
• Verma P. Generalized pigmented purpuric dermatosis in a boy treated with narrow-band-ultraviolet B therapy. Pediatr Dermatol. 2013;30:e291–e292.
   PubMed Web of Science ®Google Scholar
• Dhali TK, Chahar M, Haroon MA. Phototherapy as an effective treatment for Majocchi's disease–case report. An Bras Dermatol. 2015;90:96–99.
   PubMed Web of Science ®Google Scholar
• Hilerowicz Y, Sprecher E, Gat A, et al. Successful treatment of Schamberg's disease with fractional non-ablative 1540 nm erbium:glass laser. J Cosmet Laser Ther. 2018;16:1–4.
   Google Scholar
• D’Ambrosia RA, Rajpara VS, Glogau RG. The successful treatment of Schamberg's disease with the 595 nm vascular laser. Dermatol Surg. 2011;37:100–101.
   PubMed Web of Science ®Google Scholar
• Manolakos DA, Weiss J, Glick B, et al. Treatment of Schamberg's disease with advanced fluorescence technology. J Drugs Dermatol. 2012;11:528–529.
   PubMed Web of Science ®Google Scholar
• Kim SK, Kim EH, Kim YC. Treatment of pigmented purpuric dermatosis with topical photodynamic therapy. Dermatology (Basel). 2009;219:184–186.
   PubMed Web of Science ®Google Scholar
• Hryhorenko EA, Oseroff AR, Morgan J, et al. Antigen-specific and -nonspecific modulation of the immune response by aminolevulinic-acid-based photodynamic therapy. Immunopharmacology. 1998;40:231–240.
   PubMedGoogle Scholar
• Saw CL, Olivo M, Chin WW, et al. Transport of hypericin across chick chorioallantoic membrane and photodynamic therapy vasculature assessment. Biol Pharm Bull. 2005;28:1054–1060.
   PubMed Web of Science ®Google Scholar
• Vedak P, Nazarian RM, Kroshinsky D. A case of eczematid-like purpura of Doucas and Kapetanakis in a child. Pediatr Dermatol. 2015;32:291–292.
   PubMed Web of Science ®Google Scholar